Navigation Links
Clemson hosting scientists who study devastating diseases
Date:10/24/2013

Clemson University is hosting the region's leading scientists for discussions about the causative agents of some of the most devastating and intractable diseases of humans, including malaria, amoebic dysentery, sleeping sickness, Chagas disease and fungal meningitis.

The Cell Biology of Eukaryotic Pathogens Symposium takes place Friday on the Clemson campus and provides an environment for scientific discussions centered on current research projects involving eukaryotic pathogens.

"This daylong meeting will offer valuable insight and encourage collaboration among researchers of all levels of expertise from both Clemson's Eukaryotic Pathogen Innovation Center and the University of Georgia's Center for Tropical and Emerging Global Diseases," said James Morris, professor in Clemson's Eukaryotic Pathogens Innovation Center and department of genetics and biochemistry.

This symposium will include presentations by leading researchers, a poster session and a keynote presentation by John Perfect, James B. Duke Professor in Duke University's department of medicine, chief of the Division of Infectious Diseases and director of the Mycology Research Unit.

The Cell Biology of Eukaryotic Pathogens Symposium is organized and funded by American Society for Cell Biology, Clemson University Eukaryotic Pathogens Innovation Center, University of Georgia Center for Tropical and Emerging Global Diseases, Clemson University genetics and biochemistry department and the College of Agriculture, Forestry and Life Sciences.


'/>"/>

Contact: James Morris
jmorri2@clemson.edu
864-656-0293
Clemson University
Source:Eurekalert

Page: 1

Related biology news :

1. Clemson plant breeders roll out new oat variety
2. Clemson, Coastal Carolina universities to set hundreds of sensors in Savannah River
3. Clemson scholar receives top agriculture science award
4. Clemson plant pathologist working to raise cucurbit yields, lower production costs
5. Clemson University researchers: What happens to peaches when the chill is gone?
6. Clemson University researchers to study oil and gas operations impact on Gulf Coast pelicans
7. Clemson researchers: Different forage affects beef cattle weight, taste
8. Clemson University study points to possible treatment for brain disorders
9. Stanford scientists develop gene therapy approach to grow blood vessels in ischemic limbs
10. Queens scientists seek vaccine for Pseudomonas infection
11. Scientists produce eye structures from human blood-derived stem cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... Vigilant Solutions , a vehicle location ... announced today the appointment of retired FBI special agent ... business development. Mr. Sheridan brings more than ... focus on the aviation transportation sector, to his new ... Sheridan served as the Aviation Liaison Agent Coordinator (ALAC) ...
(Date:3/13/2017)... Future of security: Biometric Face Matching software  ... ... DERMALOGs Face Matching enables to match face pictures against each other or against ... (PRNewsFoto/Dermalog Identification Systems) ... Matching" is the fastest software for biometric Face Matching on the market. The ...
(Date:3/7/2017)... March 7, 2017   HireVue , the leading ... companies identify the best talent, faster, today announced the ... Officer (CSO) and Diana Kucer as Chief ... seasoned executive team poised to drive continued growth in ... a year of record bookings in 2017. ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... Research and Markets has announced the ... to their offering. ... The Global Market for Bioproducts Should Reach ... a CAGR of 8.9%, This research report ... seven major product segments: bio-derived chemicals, biofuels, pharmaceuticals (biodrugs and ...
(Date:3/23/2017)... Colo. , March 23, 2017  GlobeImmune, Inc. ... agreement for the sale of 12,835,490 shares of its ... NantWorks  ecosystem of companies. In connection with the sale of ... $100,000 in cash and issue to GlobeImmune 200,000 shares, ... stock. "We are pleased to enter ...
(Date:3/23/2017)... SEATTLE , March 23, 2017 ... translational development of novel therapies in immuno-oncology, today ... to lead" small molecule compounds that activate interferon ... (RLR) pathways and demonstrate immune-mediated tumor regression in ... in the study who demonstrated complete tumor regression ...
(Date:3/23/2017)... Colo. , March 23, 2017  Agriculture technology ... Series A financing and note conversion to commercialize its ... Planet is focused on developing products that are simultaneously ... $30 million in the last 18 months. This latest ... North Bridge Venture Partners. The company,s ...
Breaking Biology Technology: